(Total Views: 742)
Posted On: 08/01/2022 5:32:47 PM
Post# of 145879
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
SEC Filing Alert
NT 10-K: Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT
CytoDyn, Inc. (the “Company”) is unable to file, without unreasonable effort and expense, its Annual Report on Form 10-K for the fiscal year ended May 31, 2022 (the “Form 10-K”) because it requires additional time to complete the external audit of those statements included in the Form 10-K. The Company has experienced unexpected delays in completing the external audit due to the time required to evaluate alternative accounting treatment of non-cash expense related to settlement of convertible debt with equity instruments. The Form 10-K is expected to be filed not later than August 15, 2022 .
https://ir.stockpr.com/cytodyn/sec-filings-em...xnt10k.htm
NT 10-K: Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT
CytoDyn, Inc. (the “Company”) is unable to file, without unreasonable effort and expense, its Annual Report on Form 10-K for the fiscal year ended May 31, 2022 (the “Form 10-K”) because it requires additional time to complete the external audit of those statements included in the Form 10-K. The Company has experienced unexpected delays in completing the external audit due to the time required to evaluate alternative accounting treatment of non-cash expense related to settlement of convertible debt with equity instruments. The Form 10-K is expected to be filed not later than August 15, 2022 .
https://ir.stockpr.com/cytodyn/sec-filings-em...xnt10k.htm
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)
My comments are just my opinions and should NOT be taken as investment advice.